Pfizer to keep supplying medicine to Russia; will donate profits from drugs sold there to Ukrainian 'causes'

3
1
Favorite

Pfizer to keep supplying medicine to Russia; will donate profits from drugs sold there to Ukrainian 'causes'

Dow Jones2022-03-14

MW Pfizer to keep supplying medicine to Russia; will donate profits from drugs sold there to Ukrainian 'causes'

Pfizer Inc. $(PFE)$ said Monday that it will continue to supply medicines to Russia but it plans to donate all profits to organizations that provide humanitarian support to Ukraine. The drug maker also said it will not start new clinical trials in Russia and will stop recruiting new participants for ongoing studies. Pfizer does not break out revenue from Russia in its financial statements. The company's stock is down 14.9% so far this year, while the broader S&P 500 has declined 11.8%. Corporate Pfizer: Media Relations +1 (212) 733-7410 PfizerMediaRelations@pfizer.com

-Jaimy Lee

$(END)$ Dow Jones Newswires

March 14, 2022 08:18 ET (12:18 GMT)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment（1）

TCT
·2022-03-14
Good
Reply
1
Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2219271988?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2022-03-14 20:18","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2219271988","market":"hk","top_or_hot":-1,"title":"Pfizer to keep supplying medicine to Russia; will donate profits from drugs sold there to Ukrainian 'causes'","media":"Dow Jones","content":"<html><body><font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nMW Pfizer to keep supplying medicine to Russia; will donate profits from drugs sold there to Ukrainian 'causes'\n</p>\n<p>\n  Pfizer Inc. <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> said Monday that it will continue to supply medicines to Russia but it plans to donate all profits to organizations that provide humanitarian support to Ukraine. The drug maker also said it will not start new clinical trials in Russia and will stop recruiting new participants for ongoing studies. Pfizer does not break out revenue from Russia in its financial statements. The company's stock is down 14.9% so far this year, while the broader S&amp;P 500  has declined 11.8%. Corporate Pfizer: Media Relations +1 (212) 733-7410 PfizerMediaRelations@pfizer.com \n</p>\n<p>\n  -Jaimy Lee \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/END\">$(END)$</a> Dow Jones Newswires\n</p>\n<p>\n  March 14, 2022 08:18 ET (12:18 GMT)\n</p>\n<p>\n  Copyright (c) 2022 Dow Jones &amp; Company, Inc.\n</p>\n</font></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pfizer to keep supplying medicine to Russia; will donate profits from drugs sold there to Ukrainian 'causes'</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPfizer to keep supplying medicine to Russia; will donate profits from drugs sold there to Ukrainian 'causes'\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-03-14 20:18 GMT+8&nbsp;&nbsp;&nbsp;<a href=http://dowjonesnews.com/newdjn/logon.aspx?AL=N><strong>Dow Jones</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>MW Pfizer to keep supplying medicine to Russia; will donate profits from drugs sold there to Ukrainian 'causes'\n\n\n  Pfizer Inc. $(PFE)$ said Monday that it will continue to supply medicines to Russia ...</p>\n\n<a href=\"http://dowjonesnews.com/newdjn/logon.aspx?AL=N\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4534","symbol_name":"瑞士信贷持仓","start_time":0,"source_url":"http://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2219271988","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2219271988","pubTimestamp":1647260280,"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"MW Pfizer to keep supplying medicine to Russia; will donate profits from drugs sold there to Ukraini","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4534":"瑞士信贷持仓","BK4581":"高盛持仓","BK4550":"红杉资本持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","PFE":"辉瑞","BK4568":"美国抗疫概念","BK4007":"制药"},"translate_title":"辉瑞将继续向俄罗斯提供药物；将把在那里出售的药物的利润捐给乌克兰的“事业”","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PFE":1},"content_text":"MW Pfizer to keep supplying medicine to Russia; will donate profits from drugs sold there to Ukrainian 'causes'\n\n\n  Pfizer Inc. $(PFE)$ said Monday that it will continue to supply medicines to Russia but it plans to donate all profits to organizations that provide humanitarian support to Ukraine. The drug maker also said it will not start new clinical trials in Russia and will stop recruiting new participants for ongoing studies. Pfizer does not break out revenue from Russia in its financial statements. The company's stock is down 14.9% so far this year, while the broader S&P 500  has declined 11.8%. Corporate Pfizer: Media Relations +1 (212) 733-7410 PfizerMediaRelations@pfizer.com \n\n\n  -Jaimy Lee \n\n\n \n\n\n$(END)$ Dow Jones Newswires\n\n\n  March 14, 2022 08:18 ET (12:18 GMT)\n\n\n  Copyright (c) 2022 Dow Jones & Company, Inc.","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":9032954120,"gmtCreate":1647266674822,"gmtModify":1676534209736,"author":{"id":"3571881968134546","authorId":"3571881968134546","name":"TCT","avatar":"https://static.tigerbbs.com/817788e0e4214dd64f6bc2d3e0bea2eb","vip":1,"hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","crmLevel":5,"crmLevelSwitch":1,"idStr":"3571881968134546","authorIdStr":"3571881968134546"},"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9032954120","repostId":2219271988,"repostType":2,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":3,"commentSize":1,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}